MicroRNA-146a deficiency delays wound healing in normal and diabetic mice
Bi X, Zhou L, Liu Y, Gu J, and Mi Q. MicroRNA-146a deficiency delays wound healing in normal and diabetic mice. Adv Wound Care (New Rochelle) 2021.
Adv Wound Care
OBJECTIVE: MiRNAs are important regulators of inflammation and wound healing. However, the mechanisms through which miRNAs regulate wound healing under normal and diabetic conditions are poorly understood. We aimed to determine the effects of miR-146a on the pathogenesis of wound healing in normal and streptozotocin (STZ)-induced diabetic mice.
APPROACH: Wild-type (WT) and miR-146a knockout (KO) mice were induced to develop diabetes with STZ. Next, skin and corneal wounds were produced and measured. Percent wound closure and histology were evaluated. Inflammation at wound sites was analyzed using flow cytometry, RT-PCR, and Western blot.
RESULTS: Healing of wounded skin was significantly delayed in miR-146a KO compared to WT mice. However, corneal epithelial wound healing did not differ significantly in the mice with normal blood glucose, whereas corneal and skin wound healing was significantly delayed in KO mice with diabetes. Neutrophil infiltration increased in skin wounds of KO compared with normal mice. The potential mechanisms were associated with dysregulated IL-1β, TNF-α, IRAK1, TRAF6, and NF-κB signaling induced by miR-146a KO.
INNOVATION: Skin wound healing was delayed in miR-146a KO mice and enhanced inflammatory responses were mediated by the NF-κB signaling pathway.
CONCLUSIONS: Deficiency in miR-146a delayed skin wound healing by enhancing inflammatory responses in normal and diabetic mice. Therefore, miR-146a may be a potential target for modulation to accelerate skin wound healing.
ePub ahead of print